InvestorsHub Logo
Followers 24
Posts 1944
Boards Moderated 0
Alias Born 07/07/2014

Re: Axolotl post# 332

Sunday, 11/19/2017 6:49:05 PM

Sunday, November 19, 2017 6:49:05 PM

Post# of 999
1. I obviously I know what preclinical means
2. I'm just quoting what you said. That this should still be around .12 WHEN they do reach phase 3 (thats just crazy talk)
3. They have completed 4 phase 2A trials, with success.
4. You seem to be acting like this is a $5 Bio stock. It's not, it's in the early stages and the rock bottom price reflects that.

My point is some of the pre clinicals moving into phase 1s are obvious potential catalyst. It has a super low float and can run hard on any news.

i'm in and holding. OWCP ran to $3 on mostly fluff, this has way more potential and could do the same. Not saying it's worth that, but I could see this running to .50 easy.

Best of luck.